Baxalta Inc 3 SEC Filings

Filed On	Filing
29 Jul 2015	Form 3: Nader Francois, Director No securities owned
29 Jul 2015	Form 3: Ferrante Karen Jean, Director No securities owned
06 Jul 2015	Form 3: Orloff John J, See Remarks No securities owned
06 Jul 2015	Form 3: Zagame Patrice, See Remarks No securities owned
06 Jul 2015	Form 3: Stroucken Albert P L, Director No securities owned
06 Jul 2015	Form 3: Devitt Blake E, Director No securities owned
06 Jul 2015	Form 3: Fosler Gail D, Director No securities owned
06 Jul 2015	Form 3: Forsyth John D, Director No securities owned
06 Jul 2015	Form 3: Mccoy John A., See Remarks No securities owned
06 Jul 2015	Form 3: Meek David D., See Remarks No securities owned
06 Jul 2015	Form 3: Rosa-bjorkeson Dagmar, EVP and President, Biosimilars No securities owned
06 Jul 2015	Form 3: Gavin James R Iii, Director No securities owned
06 Jul 2015	Form 3: Leonardi Jacopo, EVP and President, Immunology No securities owned
06 Jul 2015	Form 3: Edwards Peter G, EVP and General Counsel No securities owned
06 Jul 2015	Form 3: Goff Brian, See Remarks No securities owned
06 Jul 2015	Form 3: Glasspool John, See Remarks No securities owned
06 Jul 2015	Form 3: Law Anne-marie, See Remarks No securities owned
09 Jun 2015	Form 3: Hockmeyer Wayne T, Director No securities owned
09 Jun 2015	Form 3: Hombach Robert J., Director No securities owned
09 Jun 2015	Form 3: Baxter International Inc, 10% owner Holds 5,000 shares of Common Stock, par value $0.01 per share

Comments